Hospital Virgen del Camino -ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2023

  1. Modulating T Cell Responses by Targeting CD3

    Cancers, Vol. 15, Núm. 4

2022

  1. IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction

    Molecular Cancer, Vol. 21, Núm. 1

  2. Therapeutic Strategies to Enhance Tumor Antigenicity: Making the Tumor Detectable by the Immune System

    Biomedicines, Vol. 10, Núm. 8